Clinical Trials Logo

Post-stroke Upper Limb Spasticity clinical trials

View clinical trials related to Post-stroke Upper Limb Spasticity.

Filter by:
  • None
  • Page 1

NCT ID: NCT03131791 Completed - Clinical trials for Post-Stroke Upper Limb Spasticity

Comparing the Radial Extracorporeal Shock Waves and Botulinum Toxin Injection for Spasticity

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Botulinum toxin type A (BoNT-A) is widely used in the clinics to reduce spasticity and improve upper limb function for post-stroke patients. However, there were no studies to compare the effect of rESWT and BoNT-A injection for treatment on spasticity.

NCT ID: NCT00432666 Completed - Clinical trials for Post-stroke Upper Limb Spasticity

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb

Start date: June 2006
Phase: Phase 3
Study type: Interventional

IncobotulinumtoxinA (Xeomin) is a botulinum toxin type A preparation free from complexing proteins, i.e. free from proteins other than the active toxin. Injected into the muscle, incobotulinumtoxinA (Xeomin) causes local weakening. Botulinum toxin type A is widely used for treatment of various neurological conditions. This study will investigate the efficacy and safety of incobotulinumtoxinA (Xeomin) in the treatment of post-stroke spasticity of the upper limb.